salivary gland neoplasm: ['Tumors of the SALIVARY GLANDS.']
Benign neoplasm: other/unspecified salivary gland
CD2_BENIGN_SALIVARY_NOS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
899 |
4. Check minimum number of eventsNone |
899 |
5. Include endpointsNone |
899 |
6. Filter based on genotype QC (FinnGen only) |
884 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Similar endpoints
↥List of similar endpoints to Benign neoplasm: other/unspecified salivary gland based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: other/unspecified salivary gland
- Benign neoplasm of major salivary glands
- Benign neoplasm of major salivary glands
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 7909 | 4345 | 3466 |
Only index persons | 6218 | 3614 | 2604 |
Unadjusted period prevalence (%) | |||
Whole population | 0.11 | 0.12 | 0.10 |
Only index persons | 0.12 | 0.13 | 0.10 |
Median age at first event (years) | |||
Whole population | 53.29 | 53.09 | 53.34 |
Only index persons | 49.87 | 49.80 | 49.95 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 884 | 467 | 417 |
Unadjusted period prevalence (%) | 0.20 | 0.18 | 0.21 |
Median age at first event (years) | 51.92 | 48.91 | 55.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_SALIVARY_NOS and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_SALIVARY_NOS | 1.304 [1.12, 1.52] | < 0.001 |
Birth year | 0.995 [0.99, 1.0] | 0.225 |
During the follow-up period (1.1.1998 — 31.12.2019), 403 out of 1694 females with CD2_BENIGN_SALIVARY_NOS died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_SALIVARY_NOS | 1.63 [1.38, 1.93] | < 0.001 |
Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 407 out of 1374 males with CD2_BENIGN_SALIVARY_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_SALIVARY_NOS.N-year risk | Females | Males |
---|---|---|
1 | 0.084% | 0.371% |
5 | 0.664% | 1.865% |
10 | 1.9% | 4.564% |
15 | 3.672% | 8.531% |
20 | 6.75% | 14.404% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SALIVARY_NOS – Benign neoplasm: other/unspecified salivary gland
GWS hits: -